Antigenemia in patients with mediterranean visceral leishmaniasis

J Clin Microbiol. 2009 Nov;47(11):3760-2. doi: 10.1128/JCM.00649-09. Epub 2009 Sep 16.

Abstract

Antigenemia in patients with Mediterranean visceral leishmaniasis (MVL) due to Leishmania infantum was retrospectively assessed by sandwich enzyme-linked immunosorbent assay (ELISA). Circulating Leishmania antigens, partially in free form, were in evidence in 53% of serum samples from immunocompetent individuals with MVL. Following successful therapy, antigenemia decline as measured by ELISA was more pronounced than antibody decrease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Animals
  • Antigens, Protozoan / blood*
  • Antiprotozoal Agents / therapeutic use
  • Enzyme-Linked Immunosorbent Assay / methods
  • Female
  • Humans
  • Leishmania infantum / isolation & purification*
  • Leishmaniasis, Visceral / blood*
  • Leishmaniasis, Visceral / drug therapy
  • Male
  • Middle Aged
  • Retrospective Studies
  • Young Adult

Substances

  • Antigens, Protozoan
  • Antiprotozoal Agents